AC Immune SA

Company Listings from SPi: AC Immune SA

You are here: Home >> SPi Company Listings >> AC Immune SA

 

AC Immune SA

Website:
http://

Search for other references to "immune" on SPi News

Latest AC Immune SA News

AC Immune Receives First Milestone Payment from Lilly in Small Molecule Tau Morphomer™ Program LAUSANNE, Switzerland, Sept. 20, 2019 (GLOBE NEWSWIRE) -- (NASDAQ: ACIU), a Swiss-based, clinical-stage biopharmaceutical company, today announced that it will receive the of C...... 12:00 GMT Friday 20th September 2019

AC Immune Receives Milestone Payment in Connection with Initiation of a Phase 2 Trial of Tau PET Tracer PI-2620 LAUSANNE, Switzerland, Sept. 17, 2019 (GLOBE NEWSWIRE) -- AC Immune SA (NASDAQ: ACIU), a Swiss-based, clinical-stage biopharmaceutical company with a broad pipeline focused on ne...... 07:00 GMT Tuesday 17th September 2019

AC Immune Awarded Michael J. Fox Foundation Grant to Accelerate Development of Parkinson’s Disease Diagnostic Imaging Agent LAUSANNE, Switzerland, Sept. 04, 2019 (GLOBE NEWSWIRE) -- AC Immune SA (NASDAQ: ACIU), a Swiss-based, clinical-stage biopharmaceutical company with a broad pipeline focused on ne...... 12:00 GMT Wednesday 4th September 2019

AC Immune Reports Q2 2019 Financial Results, Business and Clinical Update LAUSANNE, Switzerland, Aug. 14, 2019 (GLOBE NEWSWIRE) -- AC Immune SA (NASDAQ: ACIU), a Swiss-based, biopharmaceutical company with a broad clinical-stage pipeline focused on neu...... 12:00 GMT Wednesday 14th August 2019

AC Immune Announces Research Collaboration with University of Pennsylvania Focusing on Pathogenic Protein TDP-43 in Neurodegenerative Diseases LAUSANNE, Switzerland, Aug. 12, 2019 (GLOBE NEWSWIRE) -- AC Immune SA (NASDAQ: ACIU), a Swiss-based, clinical-stage biopharmaceutical company with a broad pipeline focused on neu...... 12:00 GMT Monday 12th August 2019

AC Immune Initiates Ph1b/2a Study of Anti-Phospho-Tau Vaccine in Alzheimer’s Disease LAUSANNE, Switzerland, Aug. 01, 2019 (GLOBE NEWSWIRE) -- AC Immune SA (NASDAQ: ACIU), a Swiss-based, clinical-stage biopharmaceutical company with a broad pipeline focused on neu...... 12:00 GMT Thursday 1st August 2019

AC Immune Initiates Phase 1 Study of ACI-3024 Small Molecule Tau Morphomer™, an Investigational Treatment for Alzheimer’s Disease LAUSANNE, Switzerland, July 17, 2019 (GLOBE NEWSWIRE) -- (NASDAQ: ACIU), a Swiss-based, clinical-stage biopharmaceutical company, today announced dosing of the first subject in...... 12:00 GMT Wednesday 17th July 2019

AC Immune Hosts KOL Event and Reports Initial Interim Clinical Data for ACI-24 Vaccine to Treat Alzheimer’s Disease-like Symptoms in Subjects with Down Syndrome LAUSANNE, Switzerland, July 11, 2019 (GLOBE NEWSWIRE) -- AC Immune SA (NASDAQ: ACIU), a Swiss-based, clinical-stage biopharmaceutical company with a broad pipeline focused on neu...... 13:00 GMT Thursday 11th July 2019

AC Immune Announces Election of New Chairman of the Board at Annual General Meeting LAUSANNE, Switzerland, June 28, 2019 (GLOBE NEWSWIRE) -- AC Immune SA (NASDAQ: ACIU), a Swiss-based, clinical-stage biopharmaceutical company with a broad pipeline focused on neu...... 13:36 GMT Friday 28th June 2019

AC Immune to Host Key Opinion Leader Meeting on Treating Alzheimer’s in Down Syndrome LAUSANNE, Switzerland, June 27, 2019 (GLOBE NEWSWIRE) -- AC Immune SA (NASDAQ: ACIU), a Swiss-based, biopharmaceutical company with a broad clinical-stage pipeline focused on pio...... 12:00 GMT Thursday 27th June 2019

Buy AC Immune SA
Market Reports
from SPi

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
 
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.
 
Privacy Policy | Terms and Conditions | Contact Us